College seeking input The PEI College of Pharmacists is seeking input on the following draft documents. Interested parties are asked to submit comments to firstname.lastname@example.org by December 11, 2015 at 4:00 pm. The link to the document is below:
National Pharmacy Technician Bridging Program The deadline for registration for the Winter 2016 Bridging courses, beginning in January 2016, is December 17, 2015. For more information on how to apply, please visit the Selkirk College website .
Healthy Canadians -Recalls and Safety Alerts - MedEffect Canada - For Health Professionals
New information intended for health professionals about safety and therapeutic effectiveness of marketed health products.
Ferring Inc. Canada, in consultation with Health Canada, would like to inform health care professionals of a voluntary recall of four (4) lots of BRAVELLE. The recall is due to reduced potency of the product detected during routine stability testing.
The labels on the product and the package insert currently being distributed by Hospira do not reflect the most up-to-date information and warnings. The missing information and warnings may increase the risk to patients and may result in significant patient harm requiring medical intervention. Specifically, these warnings are detailed below:
Co-administration of repaglinide and clopidogrel (a CYP2C8 inhibitor) may lead to a significant decrease in blood glucose levels due to a drug-drug interaction.
The concomitant use of repaglinide and clopidogrel is now contraindicated.
The prescriber information for GLUCONORM (repaglinide) has been updated. The prescriber information for PLAVIX (clopidogrel) is currently being updated. The prescriber information for the generic products will be updated (see Products affected).